Clinical Trial Update: Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD) [Phase 2]

View source ↗

Summary

A Phase 2 study of AZD3480 in mild to moderate Alzheimer's disease has completed. The trial evaluated efficacy, safety, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AZD3480

Snippet

Sponsor: Targacept Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED